EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.21.68 | medicine | working strategy for targeted delivery of recombinant tPA bound to magnetic nanoparticles with less than 20% of a regular dose under magnetic guidance, resulting in effective thrombolysis and restore of hemodynamics in the rat embolic model | synthetic construct |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.4.21.68 | 3.5 | - |
S-2288TM | recombinant tPA | synthetic construct | |
3.4.21.68 | 4.1 | - |
S-2288TM | recombinant tPA bound to polyacrylic acid-coated magnetite | synthetic construct |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.68 | synthetic construct | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.68 | plasminogen + H2O | - |
synthetic construct | plasmin + ? | - |
? | |
3.4.21.68 | S-2288TM + H2O | amidolytic activity of recombinant tPA bound to polyacrylic acid-coated magnetite is 87% of that of free recombinant tPA. Amidolytic activity of recombinant tPA immobilized on magnetic nanoparticles coated with dextran is only 11-24% of recombinant tPA bound to polyacrylic acid-coated magnetite | synthetic construct | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.21.68 | Tissue plasminogen activator | - |
synthetic construct |
3.4.21.68 | tPA | - |
synthetic construct |